Skip to main content
Relevium Technologies Inc. logo

Relevium Technologies Inc. — Investor Relations & Filings

Ticker · RLV ISIN · CA75942W1023 LEI · 2549006LWCN8PASUZR75 TSXV Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2023-03-16 Regulatory Filings
Country CA Canada
Listing TSXV RLV

About Relevium Technologies Inc.

http://www.releviumtechnologies.com

Relevium Technologies Inc. is a healthcare company operating within the health and wellness markets, primarily focused on growth through the identification, acquisition, and operation of established brands and businesses. The company utilizes e-commerce channels for distribution. Its product portfolio encompasses two main areas: magnetic therapy devices for pain relief, including active back, ankle, and knee supports; and a range of dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals, primarily marketed under the Bioganix brand. Relevium emphasizes proprietary product development and holds regulatory approvals, such as Natural Product Numbers (NPNs), for its nutraceutical offerings.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-03-16 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-03-16 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings by the CFO of Relevium Technologies Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3029 characters, which is relatively short and consistent with a certification letter rather than a full report.
2023-03-13 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings by the CEO of Relevium Technologies Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The document is primarily an officer certification letter, confirming the accuracy and completeness of the interim filings, but it does not contain actual financial data or substantive financial analysis itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) they reference. The document length is short (3051 characters), and it is clearly a certification rather than the report itself.
2023-03-13 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS THREE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020' and contains detailed unaudited interim financial statements including statements of financial position, operations, cash flows, and changes in equity. It is prepared under IAS 34 - Interim Financial Reporting, indicating it is a quarterly or interim report. The document length is substantial (15,000 characters), and it contains actual financial data and notes, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2023-03-13 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis – Quarterly Highlights' for the three-month period ended September 30, 2021. It contains detailed financial data, operational results, corporate highlights, and discussion of business strategy and market conditions. The presence of actual financial figures for the quarter, discussion of convertible notes, and other financial highlights confirms this is a substantive quarterly financial report. It is not merely an announcement or a certification, but a full MD&A report for an interim period. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2022
2023-03-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.